Chinook Therapeutics, Inc.

BAKER BROS. ADVISORS LP

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

1,455,202

Value ($000)

55,909

Weight

0.3%

2020 Q4 - 2023 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	55,909	0.3%	1,455,202	6/30/2023
2023 Q1	5/15/2023	33,688	0.2%	1,455,202	3/31/2023
2022 Q4	2/14/2023	66,393	0.4%	2,534,102	12/31/2022
2022 Q3	11/14/2022	49,820	0.3%	2,534,102	9/30/2022
2022 Q2	8/15/2022	44,321	0.3%	2,534,102	6/30/2022
2022 Q1	5/16/2022	38,186	0.2%	2,334,102	3/31/2022
2021 Q4	2/14/2022	38,069	0.2%	2,334,102	12/31/2021
2021 Q3	11/15/2021	24,283	0.1%	1,903,069	9/30/2021
2021 Q2	8/16/2021	15,255	0.1%	1,080,393	6/30/2021
2021 Q1	5/17/2021	11,635	0.1%	748,693	3/31/2021
2020 Q4	2/16/2021	11,874	0.0%	748,693	12/31/2020